AR022321A1 - USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE - Google Patents
USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANEInfo
- Publication number
- AR022321A1 AR022321A1 ARP000100250A ARP000100250A AR022321A1 AR 022321 A1 AR022321 A1 AR 022321A1 AR P000100250 A ARP000100250 A AR P000100250A AR P000100250 A ARP000100250 A AR P000100250A AR 022321 A1 AR022321 A1 AR 022321A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- transformed
- migrane
- convulsive
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Se describen derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada.Anticonvulsant derivatives useful for the treatment of transformed migraine are described.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11654499P | 1999-01-21 | 1999-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR022321A1 true AR022321A1 (en) | 2002-09-04 |
Family
ID=22367829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000100250A AR022321A1 (en) | 1999-01-21 | 2000-01-20 | USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR022321A1 (en) |
AU (1) | AU3582600A (en) |
WO (1) | WO2000042995A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
WO2006127184A1 (en) | 2005-05-20 | 2006-11-30 | Janssen Pharmaceutica N.V. | Process for preparation of sulfamide derivatives |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
AR058389A1 (en) | 2005-12-19 | 2008-01-30 | Janssen Pharmaceutica Nv | USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY |
AU2007253814A1 (en) | 2006-05-19 | 2007-11-29 | Janssen Pharmaceutica N.V. | Co-therapy for the treatment of epilepsy |
AU2009271362B2 (en) | 2008-06-23 | 2014-03-13 | Janssen Pharmaceutica Nv | Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
CN110346004B (en) * | 2019-08-16 | 2020-08-21 | 杭州山科智能科技股份有限公司 | Flow measurement data fusion method of dual-channel ultrasonic time difference method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
US5998380A (en) * | 1995-10-13 | 1999-12-07 | New England Medical Center Hospitals, Inc. | Treatment of migraine |
BR9712503A (en) * | 1996-10-08 | 1999-10-19 | Ortho Mcneil Pharm Inc | Anticonvulsant derivatives useful in the treatment of neuropathic pain |
-
2000
- 2000-01-20 WO PCT/US2000/001382 patent/WO2000042995A2/en active Application Filing
- 2000-01-20 AU AU35826/00A patent/AU3582600A/en not_active Abandoned
- 2000-01-20 AR ARP000100250A patent/AR022321A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000042995A2 (en) | 2000-07-27 |
WO2000042995A3 (en) | 2000-11-30 |
AU3582600A (en) | 2000-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2184127T3 (en) | DERIVATIVES OF USEFUL ANTI-CONVULSIVE SULFAMATE FOR THE TREATMENT OF OBESITY. | |
NO20005237D0 (en) | Heterocyclic substituted amides used as calpain inhibitors | |
DK0840732T3 (en) | Substituted benzolactam compounds as substance P antagonists | |
DK1109812T3 (en) | pyrrolobenzodiazepines | |
ATE302770T1 (en) | BENZIMIDAZOLE COMPOUNDS THAT HAVE NOCICEPTINE RECEPTOR AFFINITY | |
GB9801690D0 (en) | Therapeutic agents | |
TR200200579T2 (en) | Amino-thyrazolpyridine derivatives. | |
AR022321A1 (en) | USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE | |
DK1097173T3 (en) | Use of IL-2 peptides and derivatives thereof as therapeutic agents | |
AR016981A2 (en) | SYNTHETIC POLYPEPTIDES | |
SE9901077D0 (en) | Novel use | |
BR9807883A (en) | Tetrahydropyride compounds | |
SE9801494D0 (en) | Novel use | |
EA200100854A1 (en) | CALCIUM-LITICAL COMPOUNDS | |
BR9902084A (en) | Heterocycles. | |
IT1306165B1 (en) | USE OF INHIBITORS OF THE SUBSTANCE P FOR THE TREATMENT OF DENOCARCINOMAS. | |
DK1073447T3 (en) | N1-modified glycopeptides | |
AU2002211493A1 (en) | Indole derivatives as pde5-inhibitors | |
ECSP003590A (en) | CALCIOLITIC COMPOUNDS | |
DK1017681T3 (en) | Hydrazone-benzazulin derivatives, pharmaceuticals and intermediates | |
NO20005548L (en) | Mykobakterieinhibitorer | |
EA200500878A1 (en) | CALCYLYTIC COMPOUNDS | |
IT1289154B1 (en) | ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
AU2003259159A1 (en) | N-aryl-2-oxazolidinones and their derivatives | |
SE9602416D0 (en) | New forms of an organic salt of N'N-diacetylcystine |